- Germany
- /
- Medical Equipment
- /
- XTRA:SBS
Exploring Three German Growth Companies With High Insider Ownership On The German Exchange
Reviewed by Simply Wall St
Amidst a backdrop of rising inflation and economic uncertainty in Europe, the German market has shown resilience, though not without challenges as indicated by a slight decline in the DAX index. In such a climate, growth companies with high insider ownership can offer potential stability and commitment to long-term value creation, traits that might be particularly appealing to investors navigating these turbulent times.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 73.5% |
Deutsche Beteiligungs (XTRA:DBAN) | 35.3% | 31.6% |
YOC (XTRA:YOC) | 24.8% | 22.2% |
NAGA Group (XTRA:N4G) | 14.1% | 58.1% |
Exasol (XTRA:EXL) | 25.3% | 107.4% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Stratec (XTRA:SBS) | 30.9% | 22% |
elumeo (XTRA:ELB) | 25.8% | 99.1% |
Friedrich Vorwerk Group (XTRA:VH2) | 18% | 29.9% |
Redcare Pharmacy (XTRA:RDC) | 17.7% | 46.9% |
Let's explore several standout options from the results in the screener.
Redcare Pharmacy (XTRA:RDC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.39 billion.
Operations: The company generates its revenue primarily from two segments: €1.62 billion from the DACH region and €369.34 million internationally.
Insider Ownership: 17.7%
Redcare Pharmacy NV, a growth-focused company in Germany with high insider ownership, has shown significant sales improvements, reporting a rise from EUR 372.05 million to EUR 560.22 million in Q1 2024 and annual sales increasing to EUR 1.8 billion in 2023. Despite this revenue growth, the company still reported a net loss of EUR 7.81 million in Q1 2024 but reduced from the previous year's EUR 10.22 million loss. Redcare is expected to reach profitability within three years and forecasts robust sales growth between €2.3 billion to €2.5 billion for 2024, indicating strong future potential amidst leadership transitions at the executive level.
- Get an in-depth perspective on Redcare Pharmacy's performance by reading our analyst estimates report here.
- Upon reviewing our latest valuation report, Redcare Pharmacy's share price might be too optimistic.
Stratec (XTRA:SBS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Stratec SE, operating globally, specializes in designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, with a market capitalization of approximately €0.58 billion.
Operations: The company specializes in designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, generating revenue primarily from these segments.
Insider Ownership: 30.9%
Stratec SE, a German company with significant insider ownership, faces challenges despite its growth potential. Recently reporting a decline in quarterly sales to €50.87 million from €60.48 million and a reduced net income of €0.447 million, the company's financial performance has weakened compared to previous periods. However, Stratec is projected to outpace the German market with an earnings growth rate of 22% annually over the next three years and revenue growth forecasted at 8% per year, faster than the market's 5%. Despite these positive forecasts, concerns about debt coverage by operating cash flow persist alongside lower profit margins year-over-year.
- Take a closer look at Stratec's potential here in our earnings growth report.
- Our valuation report unveils the possibility Stratec's shares may be trading at a premium.
Zalando (XTRA:ZAL)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Zalando SE is a company that operates an online platform for fashion and lifestyle products, with a market capitalization of approximately €6.29 billion.
Operations: The company generates €10.40 billion from its online fashion and lifestyle platform.
Insider Ownership: 10.3%
Zalando SE, a German e-commerce giant, is navigating a challenging landscape with moderate sales growth and a recent net loss. Despite these hurdles, the company has shown resilience with an annual revenue of €10.14 billion and a significant improvement in net income to €83 million from €16.8 million year-over-year. Looking ahead, Zalando anticipates modest sales growth between 0% and 5% for 2024 but expects notable earnings expansion at an annual rate of 26.7%. While its share price remains volatile, Zalando trades at a substantial discount to its estimated fair value, suggesting potential undervaluation amidst its recovery efforts.
- Navigate through the intricacies of Zalando with our comprehensive analyst estimates report here.
- Our valuation report here indicates Zalando may be overvalued.
Seize The Opportunity
- Embark on your investment journey to our 16 Fast Growing German Companies With High Insider Ownership selection here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
If you're looking to trade Stratec, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About XTRA:SBS
Stratec
Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
Reasonable growth potential with adequate balance sheet.
Similar Companies
Market Insights
Community Narratives
